Envista Holdings Financial Activities - Other 2018-2025 | NVST

Envista Holdings financial activities - other from 2018 to 2025. Financial activities - other can be defined as the net amount of items a company reports that are too small to report separately. Additionally, this field holds the sum of items a company reports that cannot be assigned to any other standardized field in the financing activities section of the Cash Flows Statement.
Envista Holdings Annual Financial Activities - Other
(Millions of US $)
2024 $-6
2023 $-26
2022 $-9
2021 $-9
2020 $-39
2019 $-2,069
2018 $-325
2017 $-304
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.210B $2.511B
Envista Holdings Corporation manufactures and sells dental products primarily in the United States and internationally. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics and dental eye loupes to oral surgeons, prosthodontists and periodontists; Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; handpieces and associated consumables; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products. Envista Holdings Corporation is based in Brea, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $240.237B 28.89
Boston Scientific (BSX) United States $154.040B 38.56
Stryker (SYK) United States $147.507B 30.84
EssilorLuxottica (ESLOY) France $130.320B 0.00
Medtronic (MDT) Ireland $110.401B 15.65
Lonza Group Ag (LZAGY) Switzerland $51.194B 0.00
Haleon (HLN) United Kingdom $47.171B 26.90
ResMed (RMD) United States $37.523B 28.18
Agilent Technologies (A) United States $33.417B 21.78
GE HealthCare Technologies (GEHC) United States $32.959B 15.65
Terumo (TRUMY) Japan $27.294B 35.45
Koninklijke Philips (PHG) Netherlands $23.014B 16.15
Insulet (PODD) United States $21.880B 85.88
Zimmer Biomet Holdings (ZBH) United States $18.269B 11.73
Baxter (BAX) United States $15.698B 11.72
Smith & Nephew SNATS (SNN) United Kingdom $13.073B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.474B 22.53
Lantheus Holdings (LNTH) United States $5.601B 14.13
Prestige Consumer Healthcare (PBH) United States $4.184B 18.69
Perrigo (PRGO) Ireland $3.678B 9.32
Haemonetics (HAE) United States $3.510B 15.99
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.221B 23.75
GN Store Nord (GNNDY) Denmark $2.346B 19.43
QuidelOrtho (QDEL) United States $1.939B 13.34
LeMaitre Vascular (LMAT) United States $1.916B 42.83
AtriCure (ATRC) United States $1.621B 0.00
Acuren (TIC) United States $1.311B 0.00
AdaptHealth (AHCO) United States $1.182B 12.00
Neogen (NEOG) United States $1.070B 13.69
Green Thumb Industries (GTBIF) United States $1.063B 23.91
BioLife Solutions (BLFS) United States $1.036B 0.00
Phibro Animal Health (PAHC) United States $1.004B 12.83
Kestra Medical Technologies (KMTS) United States $0.906B 0.00
InMode (INMD) Israel $0.870B 8.76
CeriBell (CBLL) United States $0.710B 0.00
Evolus (EOLS) United States $0.620B 0.00
Owens & Minor (OMI) United States $0.578B 4.79
Maravai LifeSciences Holdings (MRVI) United States $0.568B 0.00
Curaleaf Holdings (CURLF) Canada $0.519B 0.00
Valneva SE (VALN) France $0.477B 0.00
Capricor Therapeutics (CAPR) United States $0.423B 0.00
Surmodics (SRDX) United States $0.415B 0.00
Tilray Brands (TLRY) Canada $0.384B 0.00
VAREX IMAGING (VREX) United States $0.328B 12.05
SNDL (SNDL) Canada $0.326B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.300B 0.00
Sanuwave Health (SNWV) United States $0.279B 0.00
Viemed Healthcare (VMD) United States $0.274B 23.10
Cerus (CERS) United States $0.262B 0.00
Sanara MedTech (SMTI) United States $0.253B 0.00
ZimVie (ZIMV) United States $0.247B 11.22
Brainsway (BWAY) Israel $0.232B 61.30
Canopy Growth (CGC) Canada $0.230B 0.00
Quanterix (QTRX) United States $0.229B 0.00
Cresco Labs (CRLBF) United States $0.228B 0.00
OraSure Technologies (OSUR) United States $0.224B 0.00
Aurora Cannabis (ACB) Canada $0.224B 66.33
Biote (BTMD) United States $0.218B 6.14
Omeros (OMER) United States $0.198B 0.00
TriSalus Life Sciences (TLSI) United States $0.198B 0.00
Organigram Global (OGI) Canada $0.182B 0.00
Utah Medical Products (UTMD) United States $0.181B 14.74
High Tide (HITI) Canada $0.177B 0.00
Verano Holdings (VRNOF) United States $0.175B 0.00
Exagen (XGN) United States $0.150B 0.00
Vireo Growth (VREOF) United States $0.131B 0.00
FitLife Brands (FTLF) United States $0.121B 14.84
Jin Medical (ZJYL) China $0.103B 0.00
Veru (VERU) United States $0.098B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.089B 0.00
Fonar (FONR) United States $0.088B 11.32
Apyx Medical (APYX) United States $0.086B 0.00
Quipt Home Medical (QIPT) United States $0.086B 0.00
MacroGenics (MGNX) United States $0.085B 0.00
TerrAscend (TSNDF) Canada $0.078B 0.00
Zynex (ZYXI) United States $0.076B 0.00
Cytosorbents (CTSO) United States $0.075B 0.00
InterCure (INCR) Israel $0.069B 0.00
Agape ATP (ATPC) $0.065B 0.00
ImmuCell (ICCC) United States $0.062B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
Nephros (NEPH) United States $0.044B 59.43
Modular Medical (MODD) United States $0.043B 0.00
United-Guardian (UG) United States $0.037B 12.89
Rockwell Medical (RMTI) United States $0.030B 0.00
Safety Shot (SHOT) United States $0.023B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
Cellectar Biosciences (CLRB) United States $0.018B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
INLIF (INLF) $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Senestech (SNES) United States $0.007B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00